Cytological examination in the diagnosis of cervical pathology
https://doi.org/10.25789/YMJ.2021.74.22
Abstract
The cytological study of the cervix was carried out in women aged 18 to 44 years. It was found that the higher rate of background and precancerous diseases of the cervix is noted in women aged 30-44 years. Early diagnosis and treatment of underlying and precancerous diseases of the cervix will contribute to contribute to improving the early diagnosis, monitoring, and prognosis of CU cancer.
Supporting agencies: The paper was written as part of R&D “The epidemiological aspects of cancer on the Far North living environment, development of modern early detection methods, and prevention methods with high-informative fundamental research. (М06;01;01)" (№ 0556-2014-0006)
About the Authors
M. P. Kirillina
Yakut Science Centre of Complex Medical Problems;
NEFU Medical Institute Clinic Laboratory
Russian Federation
Russian Federation
Kirillina Maria Petrovna – Candidate of Biological Sciences, Senior Research Scientist, Head of the laboratory of precancerogenesis and malignant tumors;
Head
I. V. Kononova
Yakut Science Centre of Complex Medical Problems
Russian Federation
Russian Federation
Kononova Irina Vasilievna – Candidate of Medical Science, Research Worker at the laboratory of precancerogenesis and malignant tumors
S. I. Sofronova
Yakut Science Centre of Complex Medical Problems
Russian Federation
Russian Federation
Sofronova Sargylana Ivanovna – Candidate of Medical Sciences, Chief Research Worker, Head of research section
P. M. Ivanov
Yakut Science Centre of Complex Medical Problems
Russian Federation
Russian Federation
Ivanov Petr Mikhaylovich – Doctor of Medicine, Professor, Senior Scientist at the laboratory of precancerogenesis and malignant tumors
A. S. Golderova
M. K. Ammosov NEFU
Russian Federation
Russian Federation
Golderova Aytalina Semenovna – Doctor of Medicine, Professor of the department of Public Health and Health Service, Common hygiene and Bioethics, Head of Research Laboratory (NIL) of cell technology and regenerative medicine based
References
1. Briko N.I. The need to control HPV-associated diseases / N.I. Briko, P.D. Lopukhov // Epidemiology and Vaccine Prevention. - 2017 .-16 (2 (93). - P. 10-15.
2. WHO. Strategies and laboratory techniques to strengthen surveillance for sexually transmitted infections. - WHO, 2014. – 100 p.
3. Kokhanevich E.V. Colpocervicoscopy / E.V. Kokhanevich, K.P. Ganina, V.V. Sumenko. - Kiev, 1997.
4. КKustarov V.N. Pathology of the cervix / V.N. Kustarov, V.A.Linde. – SPb., - 2002. – 143 p.
5. Nikulina I.E. Clinical and laboratory characteristics of the state of health of women before revealing their pathological processes of the exocervix / I.E. Nikulina // Postgraduate Bulletin of the Volga Region. - 2015. - No. 1-2. - P.30-36.
6. Novik V.I. Epidemiology of cervical cancer, risk factors, screening / V.I. Novik // Practical Oncology. - 2002. - Vol. 3, No. 3. - P.156-165.
7. Rusakevich P.S. Background and precancerous diseases of the cervix / P.S. Rusakevich. - Minsk, 1998 .- 368 p.
8. Rusakevich P.S. Diseases of the cervix: symptoms, diagnosis, treatment, prevention: ref. manual / P.S. Rusakevich. - M .: Vysh.shk., 2000 .- 368 p.
9. Tatarchuk T.F. Pathology of the cervix. What are the tasks facing the gynecologist? / T.F. Tatarchuk, T.N. Tutchenko // Reproductive endocrinology. - 2013. - No. 1 (9). - P. 39-48.
10. Photodynamic therapy of background diseases of the cervix / A.M. Torchinov, M.M. Umakhanova, R.A. Duvansky. [et al.] // Laser medicine. - 2013. - Vol. 17, issue 4. - P. 8-15.
11. Shoonaeva N.J. Pathology of the cervix: causes and problems of our time / N.J. Shoonaeva, V.A. Vybornykh, A.M. Asanbekova / Scientific Review. - 2020. - No. 4. - P.55-59.
12. Hagen B. The outcome of pregnancy after CO-2 laser ionization of the cervix / B.Hagen, F.E.Skjeldestad // Br.J.Obstet.Gynaecol. – 1993. – Vol.100, P.717-720.
13. Machado F.A. Immune response and immunotherapy in intraepithelial and invasive lesions of the uterine cervix / F.A Machabo, Janssens J.P., M.A.Michelin // Clin Exp Obster Gynecol. 2012;39(1):27-31.
14. US Preventive Services Task Force Recommendation Statement. Screening for Cervical Cancer. JAMA. 2018; 320 (320(7):674-686.
15. World Health Oragnization. International Agency for Research on Cancer. [Electronic resource]. - URL: https://gco.iarc.fr/today/home (date of access 5.04.2021)
Review
For citations:
Kirillina M.P., Kononova I.V., Sofronova S.I., Ivanov P.M., Golderova A.S. Cytological examination in the diagnosis of cervical pathology. Yakut Medical Journal. 2021;(2):88-90. https://doi.org/10.25789/YMJ.2021.74.22
Views:
18
Email this article 